Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CRXT - Clarus Therapeutics: Advancing Androgen Replacement And Metabolic Therapies

CRXT - Clarus Therapeutics: Advancing Androgen Replacement And Metabolic Therapies

Clarus Therapeutics Holdings Inc.
  • Clarus Therapeutics is a commercial stage pharmaceutical company advancing androgen replacement and metabolic therapies.
  • The Company’s lead product JATENZO was FDA approved in March 2019 and commercially available in February 2020.
  • The Company recently closed a business combination with SPAC Blue Water and commenced trading on NASDAQ, but still has a working capital deficit.

For further details see:

Clarus Therapeutics: Advancing Androgen Replacement And Metabolic Therapies
Stock Information
Company Name: Clarus Therapeutics Holdings Inc.
Stock Symbol: CRXT
Market: OTC
Website: clarustherapeutics.com
Menu
CRXT CRXT Quote CRXT Short CRXT News CRXT Articles CRXT Message Board
Get CRXT Alerts

News, Short Squeeze, Breakout and More Instantly...